Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

US Patent 8722684 · Granted May 13, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Catecholamine prodrugs for use in the treatment of Parkinson's disease2025
Compositions comprising mixtures of compounds and uses thereof2025
Formulations/compositions comprising ibrutinib2025
Crystalline forms of a MAGL inhibitor2024
Compositions comprising mixtures of compounds and uses thereof2023
Therapeutic uses of compounds having combined sert, 5-HT3 and 5-HT1a activity2023
1-[2-(2,4-dimeihylphenylsulfanyl)-phenyl]piperazine as a compound with combined 2022
1-[2-(2,4-dimeihylphenylsulfanyl)-phenyl]piperazine as a compound with combined 2022
1-[2-(2,4-dimeihylphenylsulfanyl)-phenyl]piperazine as a compound with combined 2022
Vortioxetine pyroglutamate2022
Phenyl-piperazine derivatives as serotonin reuptake inhibitors2020
Vortioxetine pyroglutamate2019